BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20622324)

  • 1. Clinical characteristics and therapeutic analysis of invasive fungal infection in chronic severe hepatitis patients.
    Hou Z; Tan D; Liu G; Xie Y; Li C; Xie J; Lu M; Liu Z; Sha X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Jun; 35(6):537-42. PubMed ID: 20622324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical features and treatment of invasive fungal infection in 47 patients with hematological malignancies].
    Zhu Y; Chen SP; Shu YG; Xu YJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):89-92. PubMed ID: 18245913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focus on fungal infections.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1997 Jul; 3(7):27-32. PubMed ID: 11364470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment of invasive fungal infections in the cancer patient: recent progress and ongoing questions.
    Kontoyiannis DP; Patterson TF
    Clin Infect Dis; 2014 Nov; 59 Suppl 5(Suppl 5):S356-9. PubMed ID: 25352631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain].
    Díaz Pedroche C; Cisneros JM; Lumbreras C; Aguado JM;
    Rev Esp Quimioter; 2005 Jun; 18(2):149-58. PubMed ID: 16130037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.
    Sinkó J; Csomor J; Nikolova R; Lueff S; Kriván G; Reményi P; Bátai A; Masszi T
    Transpl Infect Dis; 2008 Apr; 10(2):106-9. PubMed ID: 17605727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
    Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
    Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of voriconazole for treatment of invasive fungal infections in 87 cases with hematologic malignancies].
    Feng AM; Wei JY; Yu WJ
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jul; 32(7):473-5. PubMed ID: 22213868
    [No Abstract]   [Full Text] [Related]  

  • 10. Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation.
    Martin T; Sharma M; Damon L; Kaplan L; Guglielmo BJ; Working M; O'Malley R; Hwang J; Linker C
    Transpl Infect Dis; 2010 Feb; 12(1):45-50. PubMed ID: 19793068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guideline for diagnosis and treatment of deep mycosis].
    Kono S
    Rinsho Ketsueki; 2001 Jun; 42(6):452-7. PubMed ID: 11505521
    [No Abstract]   [Full Text] [Related]  

  • 12. [Update on voriconazole].
    Dtsch Med Wochenschr; 2003 Aug; 128(33):1738. PubMed ID: 12968630
    [No Abstract]   [Full Text] [Related]  

  • 13. Voriconazole treatment for less-common, emerging, or refractory fungal infections.
    Perfect JR; Marr KA; Walsh TJ; Greenberg RN; DuPont B; de la Torre-Cisneros J; Just-Nübling G; Schlamm HT; Lutsar I; Espinel-Ingroff A; Johnson E
    Clin Infect Dis; 2003 May; 36(9):1122-31. PubMed ID: 12715306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of invasive mycoses in neutropenic patients with hematologic system diseases].
    Glasmacher A; Just-Nübling G; Molitor E
    Dtsch Med Wochenschr; 1998 Feb; 123(7):191-4. PubMed ID: 9505945
    [No Abstract]   [Full Text] [Related]  

  • 15. Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy.
    Baden LR; Katz JT; Fishman JA; Koziol C; DelVecchio A; Doran M; Rubin RH
    Transplantation; 2003 Dec; 76(11):1632-7. PubMed ID: 14702539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicentre pharmacoepidemiological study of therapeutic practices in invasive fungal infections in France during 1998-1999.
    Lortholary O; Charlemagne A; Bastides F; Chevalier P; Datry A; Gonzalves MF; Michel G; Tilleul P; Veber B; Herbrecht R
    J Antimicrob Chemother; 2004 Aug; 54(2):456-64. PubMed ID: 15231769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients.
    Barnes RA; White PL; Bygrave C; Evans N; Healy B; Kell J
    J Clin Pathol; 2009 Jan; 62(1):64-9. PubMed ID: 19103864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.
    Maertens J; Theunissen K; Verhoef G; Verschakelen J; Lagrou K; Verbeken E; Wilmer A; Verhaegen J; Boogaerts M; Van Eldere J
    Clin Infect Dis; 2005 Nov; 41(9):1242-50. PubMed ID: 16206097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of new antifungal agents.
    Kauffman CA
    Curr Opin Microbiol; 2006 Oct; 9(5):483-8. PubMed ID: 16904366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical picture and therapy of endemic fungal diseases (candidiasis, mucormycosis, aspergillosis)].
    Wegmann T
    Verh Dtsch Ges Inn Med; 1971; 77():842-50. PubMed ID: 4949705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.